Valuation: Teva Pharmaceutical Industries Limited

Market Cap 41.26B 0 35.84B 33.28B 30.69B 57.82B 3,939B 58.87B 394B 154B 1,956B 155B 152B 6,579B P/E 2026 *
47.5x
P/E 2027 * 19.5x
Enterprise Value 53.14B 0 46.16B 42.86B 39.53B 74.46B 5,073B 75.81B 507B 199B 2,520B 200B 195B 8,473B EV / Sales 2026 *
3.2x
EV / Sales 2027 * 2.88x
Free-Float
88.61%
Yield 2026 *
-
Yield 2027 * -
1 day+2.43%
1 week+14.20%
Current month+11.21%
1 month+11.21%
3 months+5.39%
6 months+8.32%
Current year+8.42%
1 week 9,450
Extreme 9450
10,970
1 month 9,396
Extreme 9396
10,970
Current year 8,860
Extreme 8860
11,350
1 year 5,305
Extreme 5305
11,350
3 years 3,002
Extreme 3002
11,350
5 years 2,383
Extreme 2383
11,350
10 years 2,175
Extreme 2175
20,860
Manager TitleAgeSince
Chief Executive Officer 57 31/12/2022
Director of Finance/CFO 53 21/12/2019
Chief Operating Officer 52 02/06/2024
Director TitleAgeSince
Director/Board Member 69 31/12/2008
Chairman 78 05/02/2017
Director/Board Member 65 31/08/2015
Change 5-day change 1-year change 3-year change Capi.($)
+2.62%+14.20% - - 41.26B
-4.55%-2.61%+51.95%+151.91% 1,030B
-3.66%-1.33%+52.95%+46.62% 617B
-2.24%+0.19%+35.97%+70.64% 455B
+0.74%+0.42%+38.70%+31.78% 350B
+0.87%+0.82%+35.83%+40.49% 299B
+0.85%+1.33%+13.37%+14.77% 265B
+0.07%+3.23%+5.23%-39.40% 225B
0.00%+4.34%+28.63%+64.00% 209B
-1.09%+0.32%+14.40%+70.80% 163B
Average -0.18%+4.83%+30.78%+50.18% 401.41B
Weighted average by Cap. -0.62%+4.87%+38.70%+72.11%

Financials

2026 *2027 *
Net sales 16.58B 0 14.4B 13.38B 12.34B 23.24B 1,583B 23.66B 158B 62B 786B 62.27B 60.91B 2,644B 17.3B 0 15.03B 13.96B 12.87B 24.25B 1,652B 24.69B 165B 64.7B 820B 64.98B 63.56B 2,759B
Net income 1.14B 0 991M 920M 848M 1.6B 109B 1.63B 10.89B 4.26B 54.07B 4.28B 4.19B 182B 2.34B 0 2.03B 1.88B 1.74B 3.27B 223B 3.33B 22.32B 8.74B 111B 8.78B 8.58B 373B
Net Debt 11.88B 0 10.32B 9.58B 8.84B 16.64B 1,134B 16.94B 113B 44.41B 563B 44.6B 43.63B 1,894B 8.61B 0 7.48B 6.95B 6.41B 12.07B 822B 12.28B 82.23B 32.2B 408B 32.34B 31.63B 1,373B
Logo Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Employees
32,008
Date Price Change Volume
31/07/26 ILA 10,960.00 +2.62% 360,578
30/07/26 ILA 10,680.00 +1.14% 1,803,433
29/07/26 ILA 10,560.00 +10.17% 2,354,552
28/07/26 ILA 9,585.00 +0.89% 831,774
27/07/26 ILA 9,500.00 -0.84% 1,193,392
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
35.41USD
Average target price
41.20USD
Spread / Average Target
+16.35%

Quarterly revenue - Rate of surprise